Pharmaceutical & Medical Device Pricing & Reimbursement in Turkey
Turkey is an exciting, high-growth potential market for pharmaceutical manufacturers. Market access however, is a complicated task in Turkey and requires an excellent understanding of all stakeholders' initiatives and views.
With a real intention to change the current situation and shape advanced processes: governmental bodies, the pharma industry and leading academics are strongly advocating initiatives such as HTA establishment and increasing transparency of reimbursement processes. Although the mission ahead is complicated and is raising a number of debates, it seems
the process has started and pricing and reimbursement models will become clearer in the short to medium terms.
This event will provide a first-hand information from the people who are deeply involved in promoting advanced market access models in Turkey and wish to have a voice in such discussions.
This will be an excellent platform for a unique multi-stakeholder discussion and a reliable source of information for all manufacturers who are already active or are planning to expand their business in Turkey.
Why Attend?
- Achieve your planned pricing and reimbursement targets by understanding how Policy makers, pharma manufacturers and academics are viewing market access models in Turkey today.
- Learn more about how reimbursement applications are being assessed and which data can make the difference.
- Understand which pricing and reimbursement models are being followed in Turkey and which models may be implemented in the future.
- Meet experts who are involved in designing HTA initiatives and find out which models they are advocating.
- Network with decision makers and have a voice on future developments in a unique event that is focusing purely on market access in Turkey.
Who will benefit?
Pharmaceutical manufacturers:
Vice-Presidents, Directors, Managers involved in:Pricing & Reimbursement, Market-Access, Health Outcomes, Health Economics, Payer-Relations, Government Affairs, Regulatory Affairs, Medical, Marketing, Emerging Markets, Country Heads, Brand & Product Managers.
Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads.
Your Prestigious Speaker Panel
|
Industry Experts
Health Policy Manager Association of Research Based Pharmaceutical Companies
Director of Strategic Affairs Johnson & Johnson Medical, Turkey Chairman Turkish Research Based Medical Technology Manufacturers’ Association (ARTED)
External Affairs Director MSD, Turkey
Country Principal IMS Health, Turkey
General Manager Synthes, Turkey
Health Policy Coordinator Pfizer, Turkey
|
Payers & Policy Makers
Directorate General of Public Health Insurance Department of Medicine and Pharmacy Social Security Institution (SGK), Turkey
Leading Academics
Faculty of Economics and Administrative Sciences Department of Health Care Administration Hacettepe University, Ankara, Turkey
|